+

WO1998037055B1 - Compounds, compositions, and methods for cancer imaging and therapy - Google Patents

Compounds, compositions, and methods for cancer imaging and therapy

Info

Publication number
WO1998037055B1
WO1998037055B1 PCT/US1998/003215 US9803215W WO9837055B1 WO 1998037055 B1 WO1998037055 B1 WO 1998037055B1 US 9803215 W US9803215 W US 9803215W WO 9837055 B1 WO9837055 B1 WO 9837055B1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
methods
compounds
therapy
compositions
Prior art date
Application number
PCT/US1998/003215
Other languages
French (fr)
Other versions
WO1998037055A1 (en
Filing date
Publication date
Priority claimed from US08/802,275 external-priority patent/US5919934A/en
Application filed filed Critical
Priority to MX9911116A priority Critical patent/MX257801B/en
Publication of WO1998037055A1 publication Critical patent/WO1998037055A1/en
Publication of WO1998037055B1 publication Critical patent/WO1998037055B1/en

Links

Abstract

Disclosed are bisaminothiol and amino compounds with appended pharmacophores, complexes of these compounds with 99mTc(V)0, Re(V)0, In?+3, 67Ga+3, 90Y+3, 109Pd+2 or 105Rh+3¿, and pharmaceutical compositions containing the complexes. Also disclosed are methods of diagnosing a mammal for the presence of a mammalian tumor, methods for in vitro detection of a cancer cell in a mammalian tissue sample, and methods of treating a mammal having a tumor.

Claims

AMENDED CLAIMS
[received by the International Bureau on 10 August 1998 (10.08.98); original claims 1, 2 and 16 amended; new claims 65 and 66 added; remaining claims unchanged (4 pages)]
1. A compound, for use in radioimaging and radiotherapy, of the formula K1 or
K2
Figure imgf000003_0001
Figure imgf000003_0002
wherein:
R., and R2 are H or Me:
R3 is H, lower alkyl, lower alkylene, cycloalkyenyl, aryl, or arylalkane;
R4 and R5 are independently —
Figure imgf000003_0003
Rs is — (CH2)j — CZ — NRΪ 0 — ( Chfe) m— Rg
Figure imgf000003_0004
( CHz) j — CZ— NR! 0 — ( CH2) m — R9 ,
177 A compound as claimed in claim 1 , wherein the compound is
Figure imgf000004_0001
wherein Z, j, m, R3, R9, and R10 are as defined above, and R7 further comprises -C(CH3)2-.
3. A compound as claimed in claim 1 , wherein the compound is
Figure imgf000004_0002
wherein Z, j, m, R9 and R10 are as defined above.
78
6. A compound according to claim 1 , wherein R6 further comprises
Figure imgf000005_0001
-CH2— CH2-N
Figure imgf000005_0002
wherein R, and R, are as defined above.
79
65. A compound for use in radioimaging and radiotherapy, wherein said
compound is:
Figure imgf000006_0001
66. A compound for use in radioimaging and radiotherapy, wherein said
compound is:
Figure imgf000006_0002
80
PCT/US1998/003215 1997-02-19 1998-02-18 Compounds, compositions, and methods for cancer imaging and therapy WO1998037055A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX9911116A MX257801B (en) 1997-06-02 1998-02-18 Plant transformation methods

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/802,275 US5919934A (en) 1997-02-19 1997-02-19 Compounds, compositions, and methods for cancer imaging and therapy
US08/802,275 1997-02-19

Publications (2)

Publication Number Publication Date
WO1998037055A1 WO1998037055A1 (en) 1998-08-27
WO1998037055B1 true WO1998037055B1 (en) 1998-10-01

Family

ID=25183282

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/003215 WO1998037055A1 (en) 1997-02-19 1998-02-18 Compounds, compositions, and methods for cancer imaging and therapy

Country Status (2)

Country Link
US (1) US5919934A (en)
WO (1) WO1998037055A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751645B1 (en) * 1996-07-29 1998-12-24 Sanofi Sa AMINES FOR THE MANUFACTURE OF DRUGS TO PREVENT THE PROLIFERATION OF TUMOR CELLS
US5994409A (en) 1997-12-09 1999-11-30 U.S. Bioscience, Inc. Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
US6489312B1 (en) 1999-06-15 2002-12-03 Medimmune Oncology, Inc. Pharmaceutical formulations comprising aminoalkyl phosphorothioates
US6515131B2 (en) 2000-02-22 2003-02-04 Biostream Therapeutics, Inc. Imagining agents for diagnosis of Parkinson's disease
AU2001287287A1 (en) 2000-03-31 2001-10-15 Wake Forest University Methods and compositions utilizing an alternative splice variant of the sigma-1 receptor
EP1276718B1 (en) * 2000-04-28 2007-04-18 President And Fellows Of Harvard College Small technetium-99m and rhenium labeled agents and methods for imaging tumors
EP1417328A2 (en) * 2001-07-20 2004-05-12 Children's Medical Center Corporation Invasion complex and methods of targeting
CN102133407A (en) * 2002-03-01 2011-07-27 图兰恩教育基金管理人 Conjugates of therapeutic or cytotoxic agents and biologically active peptides
US20060159617A1 (en) * 2002-11-08 2006-07-20 Ashfaq Mahmood Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors
WO2009126160A1 (en) * 2008-04-10 2009-10-15 University Of Florida Research Foundation Compositions and methods for the treatment of prostate carcinoma
EP2766364B1 (en) 2011-08-17 2024-07-31 Merck & Cie Folate conjugates of albumin-binding entities
US10457642B2 (en) 2015-05-04 2019-10-29 The Trustees Of The University Of Pennsylvania 211-astatine containing radiotherapeutics for the treatment of cancer
JP2023526515A (en) 2020-05-20 2023-06-21 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ Methods for treating lysosomal storage diseases with histatin peptides

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4584187A (en) * 1981-04-01 1986-04-22 Wieland Donald M Imaging agent and method of use
US5154913A (en) * 1987-11-19 1992-10-13 Vanderbilt University Radioiodinated benzamines method of their use as radioimaging agents
US4925650A (en) * 1988-11-16 1990-05-15 Mallinckrodt, Inc. Technetium -99m complex for examining the renal function
FR2642972B1 (en) * 1989-02-14 1994-08-05 Inst Nat Sante Rech Med AGENTS FOR THE DIAGNOSIS AND TREATMENT OF MELANOMAS, HALOGENATED AROMATIC DERIVATIVES SUITABLE FOR USE AS SUCH AGENTS AND THEIR PREPARATION
US5122361A (en) * 1989-04-17 1992-06-16 Trustees Of The University Of Pennsylvania Dopamine receptor ligands and imaging agents
US5262175A (en) * 1989-05-10 1993-11-16 Solanki Kishor K Stabilization of radiopharmaceutical compositions
US5808091A (en) * 1991-10-29 1998-09-15 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia localizing moiety
CA2138150C (en) * 1992-07-17 2005-04-19 Josepha E. M. F. Leysen 4-amino-n-(4-methyl-4-piperidinyl)-2-methoxybenzamides
GB9223168D0 (en) * 1992-11-05 1992-12-16 Johnson Matthey Plc Improvements in molecule labelling
EP0650372A4 (en) * 1993-05-06 1996-07-03 Christy S John Compounds for cancer imaging and therapy.
US5387614A (en) * 1993-07-27 1995-02-07 University Of Iowa Research Foundation Use of sigma receptor ligands as salivary gland stimulants
US5457207A (en) * 1993-10-05 1995-10-10 Regents Of The University Of Minnesota Spirovesamicols
US5499761A (en) * 1994-01-21 1996-03-19 Reimers; Eric W. Adjustable balance golf bag

Similar Documents

Publication Publication Date Title
CA1318615C (en) Radiohalogenated compounds for site specific labeling
WO1998037055B1 (en) Compounds, compositions, and methods for cancer imaging and therapy
US5434287A (en) Bifunctional DTPA-type ligand
EP0452858B1 (en) Metal complexes of acid adducts to dioxime ligands useful in labelling proteins and other amine-containing compounds
DE3855564T2 (en) Functionalized polyamine chelating agents, their complexes and processes for their preparation
US4401592A (en) Pharmaceutical composition having antitumor activity
CA1336739C (en) Diphosphonate-derivatized macromolecules
RU94042922A (en) Novel compounds, method for their production, pharmaceutical composition
EA200100766A1 (en) QUINOLIN-2-ON-SUBSTITUTED HETEROAARYNE DERIVATIVES USED AS ANTI-TUMOR AGENTS
JPH08502719A (en) Compounds, compositions, and methods for binding bioactive agents to bioparticle surface membranes
GB1581075A (en) Radiolabeled derivatives of folic acid
CN119192214B (en) Targeted binding fibroblast activation protein multimeric compound and application thereof
WO1998037055A1 (en) Compounds, compositions, and methods for cancer imaging and therapy
WO1992011039A1 (en) Derivatized tris-catechol chelating agents
Eckelman et al. Iodinated bleomycin: an unsatisfactory radiopharmaceutical for tumor localization
EP0688313B1 (en) Ligands and metal complexes thereof
Delpassand et al. Synthesis, Biodistribution, and Estrogen Receptor Scintigraphy of Indium-111—Diethylenetriaminepentaacetic Acid–Tamoxifen Analogue
Anghileri et al. 57Co-hematoporphyrin accumulation by experimental tumors
US5635158A (en) Peptides modified by the phosphine group for marking with 99M TC and 186-188 RE or paramagnetic agents
JP2007509047A (en) Use of metal tricarbonyl complexes as chemical toxicants for radiation therapy.
Mangin et al. Synthesis of a DOTA-C-glyco bifunctional chelating agent and preliminary in vitro and in vivo study of [68 Ga] Ga-DOTA-C-glyco-RGD
Shysh et al. Radioimmunodetection of murine mammary adenocarcinoma (TA3/Ha) lung and liver metastases with radioiodinated PNA
US5633372A (en) Heterocycle based nitrogen sulfur ligands useful in radiographic imaging agents
SEKI et al. Radioimmunoassay of bleomycins
US5623077A (en) Imidazole based nitrogen sulfur ligands useful in radiographic imaging agents
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载